Real‐life effectiveness of first‐line anticancer treatments in stage IIIB/IV NSCLC patients: Data from the Czech TULUNG Registry

BACKGROUND: Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line treatments in patients with advanced/metastatic non‐small cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Brat, Kristian, Bratova, Monika, Skrickova, Jana, Barinova, Magda, Hurdalkova, Karolina, Pesek, Milos, Havel, Libor, Koubkova, Leona, Hrnciarik, Michal, Krejci, Jana, Fischer, Ondrej, Zemanova, Milada, Coupkova, Helena, Svaton, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606010/
https://www.ncbi.nlm.nih.gov/pubmed/33016001
http://dx.doi.org/10.1111/1759-7714.13679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606010/
https://www.ncbi.nlm.nih.gov/pubmed/33016001
http://dx.doi.org/10.1111/1759-7714.13679

Ejemplares similares